Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Koneksa Health

Request full access

A healthcare data analytics company that helps researchers incorporate emerging technologies into their clinical studies

New York City, United StatesFounded 2015Health Tech & Medtech

About Koneksa Health

Koneksa Health operates in the healthcare technology sector, specializing in the development of an advanced analytics platform designed to enhance clinical trials. The company serves pharmaceutical companies, research institutions, and healthcare providers by capturing, monitoring, and analyzing patient-generated data. This data is collected through mobile devices, remote biometrics, and digital health tools, ensuring compliance with industry standards. Koneksa Health's platform aggregates and links high-volume data sources, which traditional clinical trial systems cannot support, thereby improving compliance, patient experience, and the detection of treatment effects. The business model is primarily B2B, generating revenue through software licensing and service fees. Koneksa Health's market includes clinical research organizations and pharmaceutical companies looking to optimize their clinical trial processes and outcomes.

Source: Dealroom company data

At a glance

Outcome tier
Colt$25–100M revenue

Koneksa Health in the New York City ecosystem

Live from Dealroom

The Koneksa Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Merck Global Health Innovation Fund
  • Waterline Ventures
  • MBX Capital
  • Michael J. Fox Foundation for Parkinson's Research

Series A4 investors entered at this stage

  • Merck & Co.
  • Spring Mountain Capital
  • McKesson Ventures
  • Novartis

Series B and later5 investors entered at this stage

  • Matrix Capital Management
  • Takeda Ventures
  • dRx Capital
  • Velosity Capital
  • Matrix Capital Limited
Employees mapped 43 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States84.2%
🇬🇧 United Kingdom13.2%
🇨🇭 Switzerland2.6%
3 countries shown
Web traffic by country
3.2K monthly visits
across markets
🇺🇸 United States65.6%
🇮🇳 India18.8%
🇵🇱 Poland12.5%
🇵🇰 Pakistan3.1%
Top 4 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Koneksa Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Koneksa Health on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.